布德索尼德和皮对空气通风的早产羔羊的肺部和大脑有不同的影响
Hayley Grzych1, Erin Fee2, Matthew W Kemp2,3
1Division of Neonatology, Cardinal Glennon Children's Hospital, Saint Louis University, Saint Louis, MO, USA.
Pediatric research
|June 10, 2025
概括
将布德索尼德与表面活性剂结合起来,改善了早产羊羔的结果,而皮显示出极少的益处,可能会增加大脑炎症. 这表明budesonide是一种有前途的产后类固醇治疗.
科学领域:
- 新生儿生理学 新生儿生理学
- 肺部医学 肺部医学
- 神经科学是一个神经科学.
背景情况:
- 产后类固醇疗法,包括布索尼德和皮,正在探索,以减少早产婴儿的肺炎.
- 将这些与产前类固醇结合使用需要对安全性和有效性的评估.
- 过早出生的婴儿面临肺损伤和神经发育问题的风险.
研究的目的:
- 评估在早产羔羊中将产前贝塔梅他与产后布德森或水皮结合使用的安全性和有效性.
- 评估这些联合类固醇治疗对肺炎,生理学和大脑发育的影响.
主要方法:
- 产前羊被给予产前贝他他.
- 产后,羔羊接受了布德索尼德或盐水的表面活性剂,以及静脉注射的皮或盐水.
- 在通风4小时后,分析了生理参数和组织样本 (肺,肝脏,大脑).
主要成果:
- 布索尼德改善了通风,减少了肺炎,并降低了肝脏和大脑中的炎症标志物.
- 皮有轻微的生理效应,并减少了布索尼德的一些抗炎功效.
- 皮,但不是布迪索尼德,增加了大脑中的星球细胞和微质激活.
结论:
- 添加到表面活性剂中的布德索尼德对早产羔羊有益,改善肺,肝脏和大脑的结果.
- 皮可能会抵消布迪索尼德的积极作用,并诱导神经炎症.
- 由于对大脑细胞的潜在不良影响,皮和布松胺的组合需要谨慎使用.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...


